Smart Monitoring to Manage Cancer Symptom Relief
Part of Cancer clinical trials.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage III or IV cancer (advanced cancer) and are being treated at the Davidoff Center
- You are experiencing active symptoms like pain, nausea, or fatigue that need relief right now
- You have not been seeing a palliative care specialist (comfort-care doctor) in the last 3 months
- You are able and willing to wear a smartwatch and use a smartphone app to report your symptoms regularly
- You speak and read one of these languages: Hebrew, Arabic, or English
- You are 18 years old or older and able to make your own medical decisions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
This study tests whether using a wearable watch and smartphone app to track activity and fitness can help monitor health in people with hormone receptor–positive, HER2-negative metastatic breast cancer while they take standard hormone therapy plus palbociclib. It mainly requires that you are already on these medicines for at least three months and can use the devices reliably.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.